Cannara Biotech Inc (TSXV:LOVE)
C$ 0.69 0 (0%) Market Cap: 62.11 Mil Enterprise Value: 108.43 Mil PE Ratio: 11.50 PB Ratio: 0.78 GF Score: 55/100

Cannara Biotech Inc Investor Call Transcript

Aug 17, 2022 / 06:00PM GMT
Release Date Price: C$1.05
Operator

Greetings. Welcome to the Cannara Biotech investor presentation. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to spokesperson, Glen Akselrod. Thank you. You may begin.

Glen Akselrod
Bristol Capital Ltd. - IR

Thank you, Alex. And thank you, everybody, for joining our webcast today with Cannara Biotech. The purpose of today's presentation is just to give our audience a better understanding of the business through a PowerPoint presentation and then questions with management.

The discussion is going to be led by Nicholas Sosiak, CFO. You should see the presentation through the webcast. If you'd like to get a copy and you don't have one, simply email me at [email protected]. We're going to break for Q&A at the end of the formal presentation. And when we do break, we encourage questions.

And again, as a reminder, we're only going to take the questions through the web portal. If you're listening over the telephone, please access the web link that we sent earlier today. Remember, you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot